Joint action on support to coordinated and expedited assessment of clinical trials for COVID-19 therapeutics holds an information session for CTR stakeholders to inform and clarify any question before its start.
|10-10.15 h:||Introduction of the Joint Action EU4 Health CT Cure : Expedited assessment of COVID 19 therapeutics.
Edit Szepessi ( European Commission DG Health and Food safety, Pharmaceuticals , Policy officer )
|10.15h-10.30 h:||Highlights of the project EU4 Health CT Cure : Team members , Structure , Deliverables.
Greet Musch ( Federal Agency for Medicinal and Health Products , General Director Pre-authorisation)
|10.30h-11h:||Best Practice Guide for expedited assessment of multi-national COVID 19 therapeutic trials.
Ann Marie Janson Lang ( Swedish Medicinal Product Agency , Co-Chair CTFG)
|11h-11.45h:||Questions and Answers|
|11.45h-12h||Wrap up and close of the meeting.
Edit Szepessi ( European Commission DG Health and Food safety, Pharmaceuticals , Policy officer)